Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.
Author
McDonald, Timothy J.
McEneny, J.
Pearson, E. R.
Thanabalasingham, G.
Szopa, M.
Shields, Beverley
Ellard, Sian
Owen, K. R.
Malecki, M. T.
Hattersley, Andrew T.
Young, I. S.
Date
2012-05-18Journal
Clinica chimica acta; international journal of clinical chemistryType
Research Support, Non-U.S. Gov'tPublisher
ElsevierDOI
10.1016/j.cca.2012.02.005Rights
Archived with thanks to Clinica chimica acta; international journal of clinical chemistryMetadata
Show full item recordAbstract
The young-onset diabetes seen in HNF1A-MODY is often misdiagnosed as Type 2 diabetes. Type 2 diabetes, unlike HNF1A-MODY, is associated with insulin resistance and a characteristic dyslipidaemia. We aimed to compare the lipid profiles in HNF1A-MODY, Type 2 diabetes and control subjects and to determine if lipids can be used to aid the differential diagnosis of diabetes sub-type.